Vigilance regarding immune thrombocytopenic purpura after COVID-19 vaccine

INTRODUCTION: Based on the severity of thrombocytopenia, patients with immune thrombocytopenic purpura (ITP) are at an increased risk of mucocutaneous or major bleeding. DISCUSSION: There has been an increased risk of ITP after administration of various vaccines like influenza, measles-mumps-rubella...

Descripción completa

Detalles Bibliográficos
Autores principales: Saudagar, Vrushali, Patil, Satish, Goh, Shaun, Pothiawala, Sohil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8011062/
https://www.ncbi.nlm.nih.gov/pubmed/33788135
http://dx.doi.org/10.1007/s11845-021-02614-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8011062/
https://www.ncbi.nlm.nih.gov/pubmed/33788135
http://dx.doi.org/10.1007/s11845-021-02614-2

Ejemplares similares